Trials / Terminated
TerminatedNCT01850589
Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to prove that the use of Bupropion with counseling works better than counseling alone for patients to quit smoking. The belief is that overall, there is a small percentage of patients who quit smoking all together.
Detailed description
The objective of the current investigation is to evaluate the effectiveness of an intensive verses conservative smoking cessation program in patients with peripheral arterial disease in an outpatient setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aggressive Therapy | Pharmacotherapy adjuncts offered at no cost are as follows: * Chantix (varenicline) GlaxoSmithKline, * Zyban (bupropion) Pfizer,and Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline. |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2013-05-09
- Last updated
- 2015-08-03
- Results posted
- 2015-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01850589. Inclusion in this directory is not an endorsement.